Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03804021 · ClinicalTrials.gov registry record

Long-Term Follow-up Study of ADVM-043

A clinical trial of Alpha-1 Antitrypsin Deficiency, sponsored by Adverum Biotechnologies.

Completed
Registry status
6
Enrollment target
2
Study locations

NCT03804021 is a study of Alpha-1 Antitrypsin Deficiency that has completed, run by Adverum Biotechnologies. The registered enrollment target is 6 participants, below the 3,078-participant average among 18 other Alpha-1 Antitrypsin Deficiency trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03804021, a study of Alpha-1 Antitrypsin Deficiency, has completed, sponsored by Adverum Biotechnologies.

COMPLETED
Registry status
6 participants
Enrollment target
2
Study locations

Study Summary

ADVM-043-03 is a long-term follow-up (LTFU) study of subjects who participated in the ADVM-043-01 (NCT02168686) multi-center gene therapy clinical study (ADVANCE) that evaluated ADVM-043 for the treatment of Alpha-1 Antitrypsin (A1AT) deficiency.

Conditions Studied

Alpha-1 Antitrypsin Deficiency

Interventions

  • GENETIC No Intervention

Study Locations (2)

Florida

  • University of Florida - Gainesville

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2018-12-27
Est. Completion 2021-12-06

Sponsor

Adverum Biotechnologies

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03804021

The ClinicalTrials.gov registry entry for NCT03804021 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,078-participant average among 18 other Alpha-1 Antitrypsin Deficiency trials with a reported enrollment target (100% lower). The listed sponsor is Adverum Biotechnologies, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alpha-1 Antitrypsin Deficiency appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT03804021 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, South Carolina.

Frequently Asked Questions

What is clinical trial NCT03804021 about?

NCT03804021 is a clinical study titled "Long-Term Follow-up Study of ADVM-043". ADVM-043-03 is a long-term follow-up (LTFU) study of subjects who participated in the ADVM-043-01 (NCT02168686) multi-center gene therapy clinical study (ADVANCE) that evaluated ADVM-043 for the treatment of Alpha-1 Antitrypsin (A1AT) deficiency.

What is the current status of trial NCT03804021?

This trial is currently completed. The enrollment target is 6 participants. The study started on 2018-12-27. Estimated completion is 2021-12-06.

What conditions does trial NCT03804021 study?

This clinical trial studies the following conditions: Alpha-1 Antitrypsin Deficiency.

What interventions are being tested in trial NCT03804021?

The interventions under investigation include: No Intervention (GENETIC).

Who is sponsoring clinical trial NCT03804021?

This trial is sponsored by Adverum Biotechnologies, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03804021 being conducted?

This trial has 2 study locations across Florida, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alpha-1 Antitrypsin Deficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alpha-1 Antitrypsin Deficiency

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.